Literature DB >> 19061580

Doxycycline for the treatment of cutaneous leishmaniasis.

A Masmoudi, A Dammak, H Chaaben, N Maalej, F Akrout, H Turki.   

Abstract

The incidence of cutaneous leishmaniasis has shown a resurgence in recent years in Tunisia. Because of the toxicity and high cost of pentavalent antimonials we have sought alternative medications. In a study of 14 patients with cutaneous leishmaniasis, ten patients achieved complete clinical regression of the lesions with oral administration of doxycycline, 200mg per day, for 15-30 days.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19061580

Source DB:  PubMed          Journal:  Dermatol Online J        ISSN: 1087-2108


  6 in total

1.  Old World cutaneous leishmaniasis: diagnosis and treatment.

Authors:  Abderrahmen Masmoudi; Wala Hariz; Slaheddine Marrekchi; Mariem Amouri; Hamida Turki
Journal:  J Dermatol Case Rep       Date:  2013-06-30

2.  Case Report: Visceral Leishmaniasis Falsely Diagnosed as Q Fever.

Authors:  Ankush Dhariwal; Sarah Jawad; Tihana Bicanic
Journal:  Am J Trop Med Hyg       Date:  2020-11       Impact factor: 2.345

Review 3.  Advances in Development of New Treatment for Leishmaniasis.

Authors:  Juliana Perrone Bezerra de Menezes; Carlos Eduardo Sampaio Guedes; Antônio Luis de Oliveira Almeida Petersen; Deborah Bittencourt Mothé Fraga; Patrícia Sampaio Tavares Veras
Journal:  Biomed Res Int       Date:  2015-05-11       Impact factor: 3.411

4.  Leishmaniasis recidivans in a nonendemic area that responded to doxycycline.

Authors:  S Pragna; R Sivayogana; R Sudha; S Vindu
Journal:  J Postgrad Med       Date:  2020 Oct-Dec       Impact factor: 1.476

5.  Quantum Biochemistry Screening and In Vitro Evaluation of Leishmania Metalloproteinase Inhibitors.

Authors:  Cláudia Jassica Gonçalves Moreno; Henriqueta Monalisa Farias; Rafael Medeiros; Talita Brito; Johny Oliveira; Francimar Lopes de Sousa; Mayara Jane Campos de Medeiros; Bruno Amorim; Gabriela Santos-Gomes; Daniel Pontes; Hugo Alexandre Oliveira Rocha; Nilton Fereira Frazao; Marcelo Sousa Silva
Journal:  Int J Mol Sci       Date:  2022-08-02       Impact factor: 6.208

6.  Identification of potent chemotypes targeting Leishmania major using a high-throughput, low-stringency, computationally enhanced, small molecule screen.

Authors:  Elizabeth R Sharlow; David Close; Tongying Shun; Stephanie Leimgruber; Robyn Reed; Gabriela Mustata; Peter Wipf; Jacob Johnson; Michael O'Neil; Max Grögl; Alan J Magill; John S Lazo
Journal:  PLoS Negl Trop Dis       Date:  2009-11-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.